Laboratories across the world are increasingly adopting chemiluminescence immunoassay (CLIA) technology to label antibodies. Chemiluminescent methods serve as important tools in biomedical research. The number of clinical tests incorporating CLIA techniques is forecast to be leveraged, attributed to technological breakthroughs in disease diagnostics and rise in demand for preventive diagnostics and treatment monitoring.
For detailed insights on enhancing your product footprint, request for a sample here – https://www.factmr.com/connectus/sample?flag=S&rep_id=4734
On the back of these trends, the global Chemiluminescence Immunoassay market is projected to expand positively at a CAGR of 6.4% in the forecast period (2020-2025). Besides, international collaborations amongst global laboratories as well as rising test volumes has necessitated adoption of semi-automation and integration of testing facilities. This is anticipated to be a major driver behind the growth of the CLIA market.
For critical insights on this market, request for methodology here – https://www.factmr.com/connectus/sample?flag=RM&rep_id=4734
Global Chemiluminescence Immunoassays (CLIA) Market Segmentation
Fact.MR has studied the global chemiluminescence immunoassays (CLIA) market with detailed segmentation on the basis of application, product, end-user and key regions.
|
Application |
Product |
End-User |
Key Regions |
|
Endocrine Disorders |
Analyzers: Fully-automated Semi-automated |
Hospitals |
North America |
|
Oncology |
Reagents: Luminophore Markers Enzymatic Markers |
Clinical Laboratories |
Europe |
|
Infectious Diseases |
Consumables |
Pharmaceutical & Biological Industries |
Asia Pacific |
|
Hepatitis and Retrovirus |
|
Others |
Latin America |
|
Cardiovascular Disorders |
|
|
Middle East & Africa |
|
Allergy |
|
|
|
|
Autoimmunity |
|
|
|
|
Drug Discovery & Development |
|
|
|
|
Others |
|
|
|
“Expansion of test offerings in innovative disease diagnosis areas and innovation in integrated immunoassay platforms are anticipated to leverage prospects for the global CLIA market in the future. Key manufacturers have capitalized on the aforementioned strategies to broad base their market footprint in key regions,” concludes a Fact.MR analyst.
For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/4734/S
Broad Basing of Testing Services, Rising Innovations to Intensify Market Competition:
Highly consolidated, the global CLIA market is dominated by the following four players: F. Hoffmann La Roche Ltd., Abbott Laboratories, Siemens Healthineers and Beckman Coulter, Inc. The increasing preference for ongoing research to expand test portfolios is anticipated to burgeon the growth of the global CLIA market. Also, innovation in multiplexed assays is poised to drive market growth.
In 2017, the FDA approved Beckman Coulter, Inc.’s Access AMH immunoassay which helps determine the presence of anti-Mullerian hormone (AMH) using recombinant human antigens. At present, the company’s product portfolio incorporates the Access 2 Immunoassay and the UniCel Dxl 600 Access Immunoassay Systems.
For comprehensive insights on this market adoption, ask an analyst here – https://www.factmr.com/connectus/sample?flag=AE&rep_id=4734
Similarly, F. Hoffmann La Roche Ltd. offers clinical chemistry and immunology analyzers and assays for small, medium and large-scale laboratories. Its products include the cobas4000 analyzer series, the cobas6000 analyzer series and the cobas8000 modular analyzer series. The third player, Abbott Laboratories, manufactures the ARCHITECT ci4100, the ARCHITECT ci8200 and the ARCHITECT ci16200 automatic analyzers.
Read More Trending and Similar Reports from Fact.MR – https://www.globenewswire.com/en/news-release/2019/07/29/1892912/0/en/Dental-Anesthetics-Sales-Will-Witness-a-Promising-Leap-as-Dental-Tourism-Continues-to-Proliferate-Says-Fact-MR.html
Explore Fact.MR’s Comprehensive Coverage on Healthcare Landscape
Bacteriophage Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2020 to 2030: https://www.factmr.com/report/bacteriophage-market
Medical Ceramics Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031: https://www.factmr.com/report/medical-ceramics-market
Cervical Dysplasia Diagnostics Market, Forecast, Trend, Analysis & Competition Tracking – Global Market Insights 2021 to 2031: https://www.factmr.com/report/cervical-dysplasia-diagnostics-market
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
US Sales Office:
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583
Corporate Headquarter:
Unit No: AU-01-H Gold Tower (AU),
Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers,
Dubai, United Arab Emirates
Email: [email protected]
Visit Our Website: https://www.factmr.com
